NCT04422067

Brief Summary

Congenital retrognathia, with or without Pierre Robin Sequence (PRS), is a rare anomaly which can be associated with chromosomal abnormalities. Respiratory and feeding consequences can be present at birth. After birth, the diagnosis of retrognathia is based on the clinical examination. Cephalometry can be used to complete the diagnosis. Several authors have proposed the use of objective quantitative ultrasound parameters for the antenatal screening of PRS. In our study, the investigators evaluated fetal cephalometry. The aim First, the investigators studied the inter- and intra-observer reproducibility of cephalometry. Second, the investigators established reference values for antenatal cephalometry in normal fetuses. Third, the investigators compared the diagnostic performance of cephalometry and the other angles described in the literature for the diagnosis of retrognathia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
68

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2019

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2019

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2019

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

June 4, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 9, 2020

Completed
Last Updated

June 11, 2020

Status Verified

June 1, 2020

Enrollment Period

4 months

First QC Date

June 4, 2020

Last Update Submit

June 8, 2020

Conditions

Keywords

with one or more fetuses suffering from a microretrognathiaCephalometryPrenatal DiagnosisFacial anglesFetal echographyMicroretrognathiadiagnosed prenatally

Outcome Measures

Primary Outcomes (1)

  • Reproducibility of cephalometry

    Reproducibility of cephalometry

    During ultrasound

Secondary Outcomes (1)

  • Perfomance of several angle to diagnose retrognatism

    During ultrasound

Study Arms (2)

Case group (Retrognatism)

All pregnant patients with one or more fetuses suffering from a microretrognathia, diagnosed prenatally and integrated into a Pierre Robin Sequence, were included. All cases were confirmed postnatally, either by a pediatric examination or by a fetopathological examination in the case of a medical termination of the pregnancy. We had 21 cases.

Other: Fetal cephalometry

Control group

47 pregnant patients with fetus without facial abnormalities

Other: Fetal cephalometry

Interventions

Fetal cephalometry

Case group (Retrognatism)Control group

Eligibility Criteria

Age18 Years - 44 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

All pregnant patients with one or more fetuses suffering from a microretrognathia, diagnosed prenatally and integrated into a Pierre Robin Sequence

You may qualify if:

  • Pregnant patient (Aged \>18years old)
  • with one or more fetuses suffering from a microretrognathia
  • diagnosed prenatally
  • integrated into a Pierre Robin Sequence

You may not qualify if:

  • Uncvertain diagnosis
  • Absence of 3D rendering volume

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Uhmontpellier

Montpellier, 34295, France

Location

MeSH Terms

Conditions

Pierre Robin Syndrome

Condition Hierarchy (Ancestors)

Jaw AbnormalitiesJaw DiseasesMusculoskeletal DiseasesMaxillofacial AbnormalitiesCraniofacial AbnormalitiesMusculoskeletal AbnormalitiesStomatognathic DiseasesStomatognathic System AbnormalitiesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Florent FUCHS, PhD

    University Hospital, Montpellier

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 4, 2020

First Posted

June 9, 2020

Study Start

May 1, 2019

Primary Completion

September 1, 2019

Study Completion

September 30, 2019

Last Updated

June 11, 2020

Record last verified: 2020-06

Locations